These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25637710)

  • 21. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.
    Copeland R; Balasubramaniam A; Tiwari V; Zhang F; Bridges A; Linhardt RJ; Shukla D; Liu J
    Biochemistry; 2008 May; 47(21):5774-83. PubMed ID: 18457417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication.
    Mao H; Chattopadhyay S; Banerjee AK
    Virology; 2009 Nov; 394(1):143-8. PubMed ID: 19747707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection.
    Banfield BW; Leduc Y; Esford L; Visalli RJ; Brandt CR; Tufaro F
    Virology; 1995 Apr; 208(2):531-9. PubMed ID: 7747425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.
    Budge PJ; Li Y; Beeler JA; Graham BS
    J Virol; 2004 May; 78(10):5015-22. PubMed ID: 15113882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence.
    Hulst MM; van Gennip HG; Vlot AC; Schooten E; de Smit AJ; Moormann RJ
    J Virol; 2001 Oct; 75(20):9585-95. PubMed ID: 11559790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes.
    Bukreyev A; Yang L; Fricke J; Cheng L; Ward JM; Murphy BR; Collins PL
    J Virol; 2008 Dec; 82(24):12191-204. PubMed ID: 18842713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition activities of polysaccharide (RG4-1) from Gentiana rigescens against RSV.
    Li X; Zhou JY; Yang QW; Chen Y; Piao YA; Li HY
    J Asian Nat Prod Res; 2011 Jun; 13(6):512-22. PubMed ID: 21623514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.
    Esimone CO; Grunwald T; Nworu CS; Kuate S; Proksch P; Uberla K
    Chemotherapy; 2009; 55(2):119-26. PubMed ID: 19155620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparanase, Heparan Sulfate and Viral Infection.
    Agelidis A; Shukla D
    Adv Exp Med Biol; 2020; 1221():759-770. PubMed ID: 32274736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of inhibitory action of concanamycins against herpes simplex virus.
    Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T
    Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.
    Heylen E; Neyts J; Jochmans D
    Biochem Pharmacol; 2017 Mar; 127():1-12. PubMed ID: 27659812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of heparan sulfate in human parainfluenza virus type 3 infection.
    Bose S; Banerjee AK
    Virology; 2002 Jun; 298(1):73-83. PubMed ID: 12093175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
    Lee JS; Lee YN; Lee YT; Hwang HS; Kim KH; Ko EJ; Kim MC; Kang SM
    Nutrients; 2015 Feb; 7(2):1021-36. PubMed ID: 25658239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation.
    Choi MS; Heo J; Yi CM; Ban J; Lee NJ; Lee NR; Kim SW; Kim NJ; Inn KS
    Biochem Biophys Res Commun; 2016 Aug; 477(3):311-6. PubMed ID: 27346133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA.
    Zhao H; De BP; Das T; Banerjee AK
    Virology; 1996 Jun; 220(2):330-8. PubMed ID: 8661384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
    Budge PJ; Graham BS
    J Antimicrob Chemother; 2004 Aug; 54(2):299-302. PubMed ID: 15254023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
    Nelson CL; Tang RS; Stillman EA
    Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.